Zonisamide Capsules Recalled for Manufacturing Deviations
Glenmark Pharmaceuticals is recalling Zonisamide Capsules 50 mg nationwide due to manufacturing deviations. The recall affects approximately 15,936 bottles across multiple lots with expiration dates in May 2022.
- Product
- ZONISAMIDE — ZONISAMIDE (ZONISAMIDE)
- Category
- Drug
- Distribution
- Distributed nationwide